Table 3

Adjusted and crude OR for severe morbidities in relation to different types of LOS

ComparisonSevere BPD*Severe ROP†Cystic PVL‡
22–31 weeks’ GA22–27 weeks22–31 weeks22–27 weeks22–31 weeks22–27 weeks
Culture-positive LOS versus no sepsis§
 Adjusted OR1.7 (1.3–2.2)1.5 (1.1–2.1)1.8 (1.2–2.8)1.8 (1.2–2.9)2.2 (1.4–3.4)2.1 (1.2–3.4)
 Crude OR6.3 (5.1–7.8)3.2 (2.5–4.1)5.7 (3.9–8.3)2.5 (1.6–3.7)3.4 (2.3–5.0)2.0 (1.3–3.3)
Gram negative LOS versus no sepsis2.5
 Adjusted OR1.3 (0.7–2.2)1.2 (0.7–2.4)1.6 (0.7–3.7)1.7 (0.8–4.0)3.2 (1.5–7.0)2.8 (1.2–6.7)
 Crude OR4.5 (2.9–7.1)2.5 (1.5–4.1)6.5 (3.3–13.0)2.6 (1.2–5.5)5.1 (2.6–10.1)2.5 (1.1–5.7)
Gram-positive LOS versus no sepsis
 Adjusted OR2.1 (1.3–3.2)1.8 (1.1–2.9)2.2 (1.2–4.1)2.2 (1.2–4.1)3.3 (1.8–6.2)3.0 (1.5–6.0
 Crude OR6.7 (4.8–9.3)3.5 (2.3–5.2)5.6 (3.2–10.0)2.7 (1.5–4.9)4.1 (2.3–7.3)2.6 (1.3–5.1)
CoNS LOS versus no sepsis
 Adjusted OR1.5 (1.1–2.3)1.6 (1.1–2.4)1.6 (0.9–3.0)1.6 (0.9–3.0)1.3 (0.6–2.6)1.4 (0.7–3.0)
 Crude OR7.0 (5.3–9.3)3.5 (2.5–4.9)5.4 (3.5–9.4)2.4 (1.4–4.2)2.4 (1.3–4.5)1.6 (0.8–3.2)
Culture-negative LOS versus no sepsis
 Adjusted OR1.6 (1.3–2.6)2.2 (1.4–3.2)1.8 (1.0–3.0)1.6 (0.9–2.8)1.0 (0.5–2.0)1.0 (0.4–2.3)
 Crude OR7.3 (5.6–9.4)4.6 (3.3–6.4)4.9 (3.1–8.0)2.1 (1.3–3.7)1.4 (0.7–2.9)0.9 (0.4–2.0)
  • Severe bronchopulmonary dysplasia (BPD); 1 value was missing. Severe retinopathy of prematurity (ROP), 9 values were missing.

  • *Adjusted for CRIB2, mechanical ventilation, antibiotic exposure in the first week of life and year of birth (2009–2013 vs 2014–2018).

  • †Adjusted for CRIB2, mechanical ventilation in the first week of life and year of birth (2009–2013 vs 2014–2018).

  • ‡Adjusted for CRIB2, Apgar 5 min, EOS, intracranial haemorrhage grade 3–4 and year of birth (2009–2013 vs 2014–2018).

  • §No sepsis; neither culture-positive EOS nor LOS, n=4457 infants.

  • CRIB2, clinical risk index for babies 2; EOS, early-onset sepsis; LOS, late-onset sepsis; PVL, periventricular leukomalacia.